INTELENCE

This brand name is authorized in United States. It is also authorized in Australia, Austria, Brazil, Canada, Croatia, Cyprus, Ecuador, Estonia, Finland, France, Hong Kong SAR China, Ireland, Israel, Japan, Lithuania, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, South Africa, Spain, Turkey, UK.

Active ingredients

The drug INTELENCE contains one active pharmaceutical ingredient (API):

1	Etravirine UNII 0C50HW4FO1 - ETRAVIRINE
	Etravirine is an non-nucleoside reverse transcriptase inhibitors (NNRTI) of human immunodeficiency virus type 1 (HIV-1). Etravirine binds directly to reverse transcriptase (RT) and blocks the RNA-dependent and DNA-dependent DNA polymerase activities by causing a disruption of the enzyme’s catalytic site.
	Read more about Etravirine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
INTELENCE Tablet	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J05AG04	Etravirine	J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AG Non-nucleoside reverse transcriptase inhibitors
Discover more medicines within J05AG04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	10301E
BR	Câmara de Regulação do Mercado de Medicamentos	514507601116211, 514514070026903
CA	Health Products and Food Branch	02306778, 02375931, 02396750
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	1951-MEE-0316, 29623-02-11
EE	Ravimiamet	1381643, 1552788, 1619254
ES	Centro de información online de medicamentos de la AEMPS	08468002
FI	Lääkealan turvallisuus- ja kehittämiskeskus	073027
FR	Base de données publique des médicaments	63514730, 64044237, 66595716
GB	Medicines & Healthcare Products Regulatory Agency	142054, 198567
HK	Department of Health Drug Office	61470
IL	מִשְׂרַד הַבְּרִיאוּת	6394, 7256
JP	医薬品医療機器総合機構	6250033F1020
LT	Valstybinė vaistų kontrolės tarnyba	1033738, 1064023, 1070790
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	347M2008
NL	Z-Index G-Standaard, PRK	100463, 119709, 88315
NZ	Medicines and Medical Devices Safety Authority	13404, 14722
PL	Rejestru Produktów Leczniczych	100198482, 100261329, 100302175
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W53549001, W61897001, W61898001
SG	Health Sciences Authority	13597P, 14535P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699593015298
US	FDA, National Drug Code	59676-570, 59676-571, 59676-572
ZA	Health Products Regulatory Authority	43/20.2.8/0780, 48/20.2.8/1301